Global Lymphedema Treatment Market Devices and Technology Demand, Top Key Players Share

Global Lymphedema Treatment Market Research Report: By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery) and By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) – Forecast to 2025

Global Market – Overview

The increasing prevalence of cancer is expected to drive the Global Lymphedema Treatment Market.

The strong clinical pipeline is likely to boost the market growth. Market players like HERANTIS PHARMA PLC, are developing curative treatment of secondary lymphedema—Lymfactin. Lymfactin is the world’s first and only clinical-stage gene therapy against lymphedema. The market potential of the drug is estimated to be around USD 650 Million

Key Players

3A Health Care (Italy)
Bio Compression Systems, Inc. (US)
Devon Medical Products (US)
HERANTIS PHARMA PLC (Finland)
Lohmann & Rauscher (Germany)
Mego Afek Ltd (US)
SIGVARIS (Switzerland)
Tactile Systems Technology Inc. (US)
Wright Therapy Products (BSN Medical) (Germany)

Market Influencer

Increased research & development in the market is estimated to influence the commercialization in the market. The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025.

Avail a Free Insights@ https://www.medgadget.com/2020/06/lymphedema-diagnostics-market-to-surpassa-valuation-of-37-6-million-by-2025-better-scope-for-diagnosis-to-boost-lymphedema-diagnostics-industry-size-global-trends-covid19-impact-research-report.html

Market Drivers

Increasing cancer cases

Lymphedema is a medical condition characterized by extra fluid buildup in the body tissues, resulting in a blockage of the lymphatic system.

It is reported that a majority of the lymphedema cases affect cancer patients. The condition can arise immediately after cancer surgery or radiation therapy. However, in certain cases, lymphedema is reported after months or years of cancer treatment. Thus, it is projected that the global lymphedema treatment market will grow, parallelly, to the increasing prevalence of cancer.

Favorable reimbursement policies
Strong pipeline in the market
Government support

Market Restraints

Limited availability of the treatment options available in the market.
Need to change the compression garments at regular intervals.
There is a need to change the compression garments at regular intervals. Such garments have a lifespan of approximately six months. This creates reluctance in lymphedema patients to opt for such treatment options, thus, restricting market growth.
Late diagnosis of lymphedema

Segmentation

By Type

Primary Lymphedema is caused by the abnormal development of the lymph system. Symptoms may occur at birth or older age. The primary lymphedema segment is estimated to hold the least market share in 2018.
Secondary Lymphedema is caused by damage to the lymph system owing to cancer treatment involving surgery, radiation therapy, and others. A majority of the patients suffered from secondary lymphedema making this the leading segment in 2018.

Access Report Details @ https://www.marketresearchfuture.com/reports/lymphedema-treatment-market-8440

By Affected Area

Lower Extremity: Lower extremity lymphedema involves the swelling of ankles, legs, and feet. This segment is estimated to hold a share of 0% in 2018.
Upper Extremity: Upper extremity lymphedema is one of the most poorly understood complications of the disease, making the segment to hold a share of 9.0% in the market in 2018.
Genitalia: This segment held the least share of the market in 2018.

TOC:

Report Prologue

2.   Market Introduction

      2.1   Definition

      2.2   Scope of the Study

            2.2.1   Research Objective

            2.2.2   Assumptions

            2.2.3   Limitations

3.   Research Methodology

      3.1   Introduction

      3.2   Primary Research

      3.3   Secondary research

      3.4   Market Size Estimation

TOC…Continued

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/8440

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

hyperpigmentation disorders treatment Overview

hyperpigmentation disorders treatment Analysis Hyperpigmentation disorder are harmless skin condition caused by darkened skin patches. Rising demand for outpatient dermabrasion procedures, increasing adoption of lasers and growing cosmetics expenditure are expected to drive the growth of the market. Additionally, rising R&D spending followed aggressive strategies by the key market players is generating awareness for the disease boosting the market to grow. The global hyperpigmentation disorders treatment Market was anticipated to held a market value of USD 3,915 million in the year 2017 and is expected to grow at a CAGR of 7.1% during the forecast period. Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462 Segmentation of The global h yperpigmentation disorders treatment market Segments has been segmented based on treatment type, dise...

Immunoassay Analyzers Market By Methods, Technologies, Clinical Review and Industry Outlook

Immunoassay Analyzers Market Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023 Market Scenario Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimburseme...

Laser Therapy Market Top Company Profiles, Latest Technology, Global Size, Industry Trends

Laser Therapy Market Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023 Market Overview: Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017-2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old...

RohitMedicalDeviceResearch

Search This Blog